These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark One)
|
|
|
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||
For the quarterly period ended
|
August 4, 2013
|
|
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||
For the transition period from
|
|
to
|
|
PVH CORP.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
13-1166910
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
200 Madison Avenue, New York, New York
|
|
10016
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(212) 381-3500
|
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
August 4,
|
|
July 29,
|
|
August 4,
|
|
July 29,
|
||||||||
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Net sales
|
$
|
1,884,439
|
|
|
$
|
1,219,620
|
|
|
$
|
3,707,484
|
|
|
$
|
2,532,469
|
|
Royalty revenue
|
62,561
|
|
|
82,513
|
|
|
129,628
|
|
|
167,973
|
|
||||
Advertising and other revenue
|
17,847
|
|
|
34,490
|
|
|
37,895
|
|
|
63,587
|
|
||||
Total revenue
|
1,964,847
|
|
|
1,336,623
|
|
|
3,875,007
|
|
|
2,764,029
|
|
||||
Cost of goods sold
|
938,759
|
|
|
593,962
|
|
|
1,897,058
|
|
|
1,264,539
|
|
||||
Gross profit
|
1,026,088
|
|
|
742,661
|
|
|
1,977,949
|
|
|
1,499,490
|
|
||||
Selling, general and administrative expenses
|
953,468
|
|
|
589,333
|
|
|
1,860,476
|
|
|
1,192,004
|
|
||||
Debt modification and extinguishment costs
|
—
|
|
|
—
|
|
|
40,395
|
|
|
—
|
|
||||
Equity in income (loss) of unconsolidated affiliates, net
|
813
|
|
|
(74
|
)
|
|
3,140
|
|
|
1,850
|
|
||||
Income before interest and taxes
|
73,433
|
|
|
153,254
|
|
|
80,218
|
|
|
309,336
|
|
||||
Interest expense
|
49,495
|
|
|
28,552
|
|
|
97,439
|
|
|
58,069
|
|
||||
Interest income
|
2,116
|
|
|
197
|
|
|
4,111
|
|
|
470
|
|
||||
Income (loss) before taxes
|
26,054
|
|
|
124,899
|
|
|
(13,110
|
)
|
|
251,737
|
|
||||
Income tax expense
|
41,963
|
|
|
34,981
|
|
|
22,812
|
|
|
66,343
|
|
||||
Net (loss) income
|
$
|
(15,909
|
)
|
|
$
|
89,918
|
|
|
$
|
(35,922
|
)
|
|
$
|
185,394
|
|
Less: Net income attributable to redeemable non-controlling interest
|
87
|
|
|
—
|
|
|
126
|
|
|
—
|
|
||||
Net (loss) income attributable to PVH Corp.
|
$
|
(15,996
|
)
|
|
$
|
89,918
|
|
|
$
|
(36,048
|
)
|
|
$
|
185,394
|
|
Basic net (loss) income per common share attributable to PVH Corp.
|
$
|
(0.20
|
)
|
|
$
|
1.24
|
|
|
$
|
(0.45
|
)
|
|
$
|
2.57
|
|
Diluted net (loss) income per common share attributable to PVH Corp.
|
$
|
(0.20
|
)
|
|
$
|
1.22
|
|
|
$
|
(0.45
|
)
|
|
$
|
2.52
|
|
Dividends declared per common share
|
$
|
0.0375
|
|
|
$
|
0.0000
|
|
|
$
|
0.1125
|
|
|
$
|
0.0750
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
August 4,
|
|
July 29,
|
|
August 4,
|
|
July 29,
|
||||||||
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Net (loss) income
|
$
|
(15,909
|
)
|
|
$
|
89,918
|
|
|
$
|
(35,922
|
)
|
|
$
|
185,394
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments, net of tax expense (benefit) of $107; $(690); $(330) and $(453)
|
(45,713
|
)
|
|
(150,188
|
)
|
|
(150,770
|
)
|
|
(133,187
|
)
|
||||
Amortization of prior service credit related to pension and postretirement plans, net of tax (benefit) of $(84); $(84); $(168) and $(168)
|
(135
|
)
|
|
(135
|
)
|
|
(271
|
)
|
|
(271
|
)
|
||||
Net unrealized and realized gain on effective hedges, net of tax expense (benefit) of $482; $(625); $(754) and $364
|
1,656
|
|
|
6,346
|
|
|
9,514
|
|
|
2,099
|
|
||||
Comprehensive (loss) income
|
(60,101
|
)
|
|
(54,059
|
)
|
|
(177,449
|
)
|
|
54,035
|
|
||||
Less: Comprehensive loss attributable to redeemable non-controlling interest
|
(1,771
|
)
|
|
—
|
|
|
(1,625
|
)
|
|
—
|
|
||||
Total comprehensive (loss) income attributable to PVH Corp.
|
$
|
(58,330
|
)
|
|
$
|
(54,059
|
)
|
|
$
|
(175,824
|
)
|
|
$
|
54,035
|
|
|
August 4,
|
|
February 3,
|
|
July 29,
|
||||||
|
2013
|
|
2013
|
|
2012
|
||||||
|
UNAUDITED
|
|
AUDITED
|
|
UNAUDITED
|
||||||
ASSETS
|
|
|
|
|
|
||||||
Current Assets:
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
$
|
628,920
|
|
|
$
|
892,209
|
|
|
$
|
261,986
|
|
Trade receivables, net of allowances for doubtful accounts of $22,121, $16,114 and $13,955
|
712,057
|
|
|
418,251
|
|
|
411,381
|
|
|||
Other receivables
|
44,212
|
|
|
23,073
|
|
|
14,284
|
|
|||
Inventories, net
|
1,348,598
|
|
|
878,415
|
|
|
909,447
|
|
|||
Prepaid expenses
|
233,659
|
|
|
157,802
|
|
|
117,826
|
|
|||
Other, including deferred taxes of $88,189, $38,310 and $53,150
|
113,199
|
|
|
67,256
|
|
|
105,014
|
|
|||
Total Current Assets
|
3,080,645
|
|
|
2,437,006
|
|
|
1,819,938
|
|
|||
Property, Plant and Equipment, net
|
693,857
|
|
|
561,335
|
|
|
484,443
|
|
|||
Goodwill
|
3,368,002
|
|
|
1,958,887
|
|
|
1,777,724
|
|
|||
Tradenames
|
2,975,764
|
|
|
2,413,809
|
|
|
2,332,811
|
|
|||
Perpetual License Rights
|
206,336
|
|
|
—
|
|
|
—
|
|
|||
Other Intangibles, net
|
850,218
|
|
|
167,196
|
|
|
150,932
|
|
|||
Other Assets, including deferred taxes of $114,320, $61,465 and $5,315
|
339,924
|
|
|
243,316
|
|
|
165,640
|
|
|||
Total Assets
|
$
|
11,514,746
|
|
|
$
|
7,781,549
|
|
|
$
|
6,731,488
|
|
|
|
|
|
|
|
||||||
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY
|
|
|
|||||||||
Current Liabilities:
|
|
|
|
|
|
||||||
Accounts payable
|
$
|
552,221
|
|
|
$
|
377,231
|
|
|
$
|
372,531
|
|
Accrued expenses, including deferred taxes of $3,329, $0 and $0
|
755,326
|
|
|
646,130
|
|
|
554,078
|
|
|||
Deferred revenue
|
29,208
|
|
|
40,239
|
|
|
41,972
|
|
|||
Short-term borrowings
|
3,447
|
|
|
10,847
|
|
|
52,791
|
|
|||
Current portion of long-term debt
|
85,000
|
|
|
88,000
|
|
|
88,021
|
|
|||
Total Current Liabilities
|
1,425,202
|
|
|
1,162,447
|
|
|
1,109,393
|
|
|||
Long-Term Debt
|
4,195,151
|
|
|
2,211,642
|
|
|
1,715,464
|
|
|||
Other Liabilities, including deferred taxes of $1,126,386, $589,796 and $501,858
|
1,841,033
|
|
|
1,154,891
|
|
|
1,125,803
|
|
|||
Redeemable Non-Controlling Interest
|
5,600
|
|
|
—
|
|
|
—
|
|
|||
Stockholders’ Equity:
|
|
|
|
|
|
||||||
Preferred stock, par value $100 per share; 150,000 total shares authorized
|
—
|
|
|
—
|
|
|
—
|
|
|||
Series A convertible preferred stock, par value $100 per share; 0, 8,000 and 8,000 total shares authorized; 0, 0 and 4,000 shares issued and outstanding (with total liquidation preference of $0, $0 and $100,000)
|
—
|
|
|
—
|
|
|
94,298
|
|
|||
Common stock, par value $1 per share; 240,000,000 shares authorized; 82,052,537; 73,324,491 and 70,951,932 shares issued
|
82,053
|
|
|
73,324
|
|
|
70,952
|
|
|||
Additional paid in capital - common stock
|
2,623,659
|
|
|
1,623,693
|
|
|
1,500,032
|
|
|||
Retained earnings
|
1,398,797
|
|
|
1,445,673
|
|
|
1,202,722
|
|
|||
Accumulated other comprehensive income (loss)
|
106
|
|
|
139,882
|
|
|
(57,524
|
)
|
|||
Less: 478,934; 413,596 and 409,440 shares of common stock held in treasury, at cost
|
(56,855
|
)
|
|
(30,003
|
)
|
|
(29,652
|
)
|
|||
Total Stockholders’ Equity
|
4,047,760
|
|
|
3,252,569
|
|
|
2,780,828
|
|
|||
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders’ Equity
|
$
|
11,514,746
|
|
|
$
|
7,781,549
|
|
|
$
|
6,731,488
|
|
|
Twenty-Six Weeks Ended
|
||||||
|
August 4,
|
|
July 29,
|
||||
|
2013
|
|
2012
|
||||
OPERATING ACTIVITIES
|
|
|
|
||||
Net (loss) income
|
$
|
(35,922
|
)
|
|
$
|
185,394
|
|
Adjustments to reconcile to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
205,348
|
|
|
67,792
|
|
||
Equity in income of unconsolidated affiliates, net
|
(3,140
|
)
|
|
(1,850
|
)
|
||
Deferred taxes
|
(23,697
|
)
|
|
15,906
|
|
||
Stock-based compensation expense
|
34,478
|
|
|
18,891
|
|
||
Debt modification and extinguishment costs
|
40,395
|
|
|
—
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Trade receivables, net
|
(14,276
|
)
|
|
46,095
|
|
||
Inventories, net
|
(34,010
|
)
|
|
(117,028
|
)
|
||
Accounts payable, accrued expenses and deferred revenue
|
(145,871
|
)
|
|
39,893
|
|
||
Prepaid expenses
|
(28,923
|
)
|
|
(8,590
|
)
|
||
Employer pension contributions
|
(30,000
|
)
|
|
(7,489
|
)
|
||
Other, net
|
97,659
|
|
|
(31,716
|
)
|
||
Net cash provided by operating activities
|
62,041
|
|
|
207,298
|
|
||
INVESTING ACTIVITIES
(1)
|
|
|
|
||||
Business acquisitions, net of cash acquired
|
(1,815,329
|
)
|
|
—
|
|
||
Purchase of property, plant and equipment
|
(105,571
|
)
|
|
(81,685
|
)
|
||
Contingent purchase price payments
|
(26,734
|
)
|
|
(25,749
|
)
|
||
Net cash used by investing activities
|
(1,947,634
|
)
|
|
(107,434
|
)
|
||
FINANCING ACTIVITIES
(1)
|
|
|
|
||||
Net proceeds from revolving credit facilities
|
346
|
|
|
40,000
|
|
||
Net payments on short-term borrowings
|
(34,673
|
)
|
|
(249
|
)
|
||
Repayment of old credit facilities
|
(900,000
|
)
|
|
(89,680
|
)
|
||
Repayment of new credit facilities
|
(181,688
|
)
|
|
—
|
|
||
Repayment of Warnaco’s previously outstanding debt
|
(197,000
|
)
|
|
—
|
|
||
Net proceeds from credit facilities
|
2,993,430
|
|
|
—
|
|
||
Payment of fees associated with issuance of senior notes
|
(16,257
|
)
|
|
—
|
|
||
Net proceeds from settlement of awards under stock plans
|
24,256
|
|
|
4,377
|
|
||
Excess tax benefits from awards under stock plans
|
15,091
|
|
|
7,082
|
|
||
Cash dividends
|
(9,203
|
)
|
|
(5,490
|
)
|
||
Acquisition of treasury shares
|
(57,121
|
)
|
|
(13,633
|
)
|
||
Payments of capital lease obligations
|
(4,655
|
)
|
|
(5,664
|
)
|
||
Net cash provided (used) by financing activities
|
1,632,526
|
|
|
(63,257
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(10,222
|
)
|
|
(7,818
|
)
|
||
(Decrease) increase in cash and cash equivalents
|
(263,289
|
)
|
|
28,789
|
|
||
Cash and cash equivalents at beginning of period
|
892,209
|
|
|
233,197
|
|
||
Cash and cash equivalents at end of period
|
$
|
628,920
|
|
|
$
|
261,986
|
|
Cash
|
|
$
|
2,179,980
|
|
Common stock (7,674 shares, par value $1.00 per share)
|
|
926,452
|
|
|
Warnaco employee replacement stock awards
|
|
39,752
|
|
|
Elimination of pre-acquisition liability to Warnaco
|
|
(9,128
|
)
|
|
Total fair value of the acquisition consideration
|
|
$
|
3,137,056
|
|
|
|
Pro Forma
|
|
Pro Forma
|
|||||||||||
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
|||||||||||
|
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
7/29/12
|
||||||||
Total revenue
|
|
$
|
1,964,847
|
|
|
$
|
1,803,015
|
|
|
$
|
3,938,037
|
|
$
|
3,743,839
|
|
Net income attributable to PVH Corp.
|
|
74,545
|
|
|
39,616
|
|
|
149,948
|
|
80,417
|
|
Cash and cash equivalents
|
|
$
|
364,651
|
|
Trade receivables
|
|
290,964
|
|
|
Other receivables
|
|
47,011
|
|
|
Inventories
|
|
452,841
|
|
|
Prepaid expenses
|
|
39,979
|
|
|
Other current assets
|
|
60,626
|
|
|
Property, plant and equipment
|
|
131,357
|
|
|
Goodwill
|
|
1,451,479
|
|
|
Tradenames
|
|
604,600
|
|
|
Perpetual license rights
|
|
206,900
|
|
|
Other intangibles
|
|
824,800
|
|
|
Other assets
|
|
144,058
|
|
|
Total assets acquired
|
|
4,619,266
|
|
|
Accounts payable
|
|
179,931
|
|
|
Accrued expenses
|
|
262,432
|
|
|
Short-term borrowings
|
|
26,927
|
|
|
Current portion of long-term debt
|
|
2,000
|
|
|
Long-term debt
|
|
195,000
|
|
|
Other liabilities
|
|
810,320
|
|
|
Total liabilities assumed
|
|
1,476,610
|
|
|
Redeemable non-controlling interest
|
|
5,600
|
|
|
Total fair value of acquisition consideration
|
|
$
|
3,137,056
|
|
|
Calvin Klein North America
|
|
Calvin Klein International
|
|
Tommy Hilfiger North America
|
|
Tommy Hilfiger International
|
|
Heritage Brands Wholesale
|
|
Total
|
||||||||||||
Balance as of February 3, 2013
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Goodwill, gross
|
$
|
207,083
|
|
|
$
|
201,542
|
|
|
$
|
198,501
|
|
|
$
|
1,196,619
|
|
|
$
|
155,142
|
|
|
$
|
1,958,887
|
|
Accumulated impairment losses
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Goodwill, net
|
207,083
|
|
|
201,542
|
|
|
198,501
|
|
|
1,196,619
|
|
|
155,142
|
|
|
1,958,887
|
|
||||||
Contingent purchase price payments to Mr. Calvin Klein
|
13,406
|
|
|
9,316
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,722
|
|
||||||
Goodwill from acquisition of Warnaco
|
443,419
|
|
|
878,786
|
|
|
—
|
|
|
—
|
|
|
129,274
|
|
|
1,451,479
|
|
||||||
Currency translation
|
(1,930
|
)
|
|
(23,954
|
)
|
|
—
|
|
|
(38,715
|
)
|
|
(487
|
)
|
|
(65,086
|
)
|
||||||
Balance as of August 4, 2013
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Goodwill, gross
|
661,978
|
|
|
1,065,690
|
|
|
198,501
|
|
|
1,157,904
|
|
|
283,929
|
|
|
3,368,002
|
|
||||||
Accumulated impairment losses
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Goodwill, net
|
$
|
661,978
|
|
|
$
|
1,065,690
|
|
|
$
|
198,501
|
|
|
$
|
1,157,904
|
|
|
$
|
283,929
|
|
|
$
|
3,368,002
|
|
|
8/4/13
|
|
2/3/13
|
|
7/29/12
|
||||||||||||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||||||||
Intangible assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Customer relationships
(1)
|
$
|
333,064
|
|
|
$
|
(54,411
|
)
|
|
$
|
278,653
|
|
|
$
|
190,383
|
|
|
$
|
(41,158
|
)
|
|
$
|
149,225
|
|
|
$
|
171,583
|
|
|
$
|
(35,213
|
)
|
|
$
|
136,370
|
|
Covenants not to compete
|
2,220
|
|
|
(2,220
|
)
|
|
—
|
|
|
2,220
|
|
|
(2,220
|
)
|
|
—
|
|
|
2,220
|
|
|
(2,190
|
)
|
|
30
|
|
|||||||||
Order backlog
(1)
|
128,196
|
|
|
(122,504
|
)
|
|
5,692
|
|
|
32,287
|
|
|
(32,287
|
)
|
|
—
|
|
|
32,287
|
|
|
(32,287
|
)
|
|
—
|
|
|||||||||
Reacquired license rights
(1)
|
566,160
|
|
|
(12,904
|
)
|
|
553,256
|
|
|
8,565
|
|
|
(3,636
|
)
|
|
4,929
|
|
|
5,921
|
|
|
(3,163
|
)
|
|
2,758
|
|
|||||||||
Total intangible assets subject to amortization
|
1,029,640
|
|
|
(192,039
|
)
|
|
837,601
|
|
|
233,455
|
|
|
(79,301
|
)
|
|
154,154
|
|
|
212,011
|
|
|
(72,853
|
)
|
|
139,158
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Intangible assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Tradenames
(1)
|
2,975,764
|
|
|
—
|
|
|
2,975,764
|
|
|
2,413,809
|
|
|
—
|
|
|
2,413,809
|
|
|
2,332,811
|
|
|
—
|
|
|
2,332,811
|
|
|||||||||
Perpetual license rights
(1)
|
206,336
|
|
|
—
|
|
|
206,336
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
Reacquired perpetual license rights
|
12,617
|
|
|
—
|
|
|
12,617
|
|
|
13,042
|
|
|
—
|
|
|
13,042
|
|
|
11,774
|
|
|
—
|
|
|
11,774
|
|
|||||||||
Total intangible assets not subject to amortization
|
3,194,717
|
|
|
—
|
|
|
3,194,717
|
|
|
2,426,851
|
|
|
—
|
|
|
2,426,851
|
|
|
2,344,585
|
|
|
—
|
|
|
2,344,585
|
|
|||||||||
Total intangible assets
|
$
|
4,224,357
|
|
|
$
|
(192,039
|
)
|
|
$
|
4,032,318
|
|
|
$
|
2,660,306
|
|
|
$
|
(79,301
|
)
|
|
$
|
2,581,005
|
|
|
$
|
2,556,596
|
|
|
$
|
(72,853
|
)
|
|
$
|
2,483,743
|
|
Fiscal Year
|
|
Amount
|
||
Remainder of 2013
|
|
$
|
28,951
|
|
2014
|
|
44,823
|
|
|
2015
|
|
44,482
|
|
|
2016
|
|
44,482
|
|
|
2017
|
|
44,482
|
|
|
2018
|
|
44,482
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Service cost, including plan expenses
|
$
|
4,823
|
|
|
$
|
4,011
|
|
|
$
|
9,420
|
|
|
$
|
7,865
|
|
Interest cost
|
6,528
|
|
|
4,530
|
|
|
13,067
|
|
|
8,986
|
|
||||
Expected return on plan assets
|
(9,658
|
)
|
|
(5,254
|
)
|
|
(19,528
|
)
|
|
(10,476
|
)
|
||||
Amortization of prior service cost
|
2
|
|
|
1
|
|
|
3
|
|
|
2
|
|
||||
Total
|
$
|
1,695
|
|
|
$
|
3,288
|
|
|
$
|
2,962
|
|
|
$
|
6,377
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Service cost, including plan expenses
|
$
|
1,119
|
|
|
$
|
814
|
|
|
$
|
2,169
|
|
|
$
|
1,787
|
|
Interest cost
|
953
|
|
|
827
|
|
|
1,810
|
|
|
1,673
|
|
||||
Amortization of prior service credit
|
(17
|
)
|
|
(16
|
)
|
|
(34
|
)
|
|
(33
|
)
|
||||
Total
|
$
|
2,055
|
|
|
$
|
1,625
|
|
|
$
|
3,945
|
|
|
$
|
3,427
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Service cost, including plan expenses
|
$
|
14
|
|
|
$
|
—
|
|
|
$
|
40
|
|
|
$
|
—
|
|
Interest cost
|
207
|
|
|
181
|
|
|
429
|
|
|
399
|
|
||||
Amortization of prior service credit
|
(204
|
)
|
|
(204
|
)
|
|
(408
|
)
|
|
(408
|
)
|
||||
Total
|
$
|
17
|
|
|
$
|
(23
|
)
|
|
$
|
61
|
|
|
$
|
(9
|
)
|
|
8/4/13
|
|
7/29/12
|
||||
|
|
|
|
||||
Senior secured term loan A facility due 2018
|
$
|
1,672,297
|
|
|
$
|
—
|
|
Senior secured term loan B facility due 2020
|
1,208,202
|
|
|
—
|
|
||
4 1/2% senior unsecured notes
|
700,000
|
|
|
—
|
|
||
7 3/8% senior unsecured notes
|
600,000
|
|
|
600,000
|
|
||
7 3/4% debentures
|
99,652
|
|
|
99,631
|
|
||
Senior secured term loan A facility due 2016 - United States dollar-denominated
|
—
|
|
|
592,000
|
|
||
Senior secured term loan A facility due 2016 - Euro-denominated
|
—
|
|
|
98,844
|
|
||
Senior secured term loan B facility due 2016 - United States dollar-denominated
|
—
|
|
|
395,000
|
|
||
Senior secured term loan B facility due 2016 - Euro-denominated
|
—
|
|
|
18,010
|
|
||
Total
|
4,280,151
|
|
|
1,803,485
|
|
||
Less: Current portion of long-term debt
|
85,000
|
|
|
88,021
|
|
||
Long-term debt
|
$
|
4,195,151
|
|
|
$
|
1,715,464
|
|
Remainder of 2013
|
$
|
42,500
|
|
2014
|
85,000
|
|
|
2015
|
116,875
|
|
|
2016
|
159,375
|
|
|
2017
|
170,000
|
|
|
2018
|
1,105,000
|
|
•
|
incur or guarantee additional debt or extend credit;
|
•
|
make restricted payments, including paying dividends or making distributions on, or redeeming or repurchasing, the Company’s capital stock or certain debt;
|
•
|
make acquisitions and investments;
|
•
|
dispose of assets;
|
•
|
engage in transactions with affiliates;
|
•
|
enter into agreements restricting the Company’s subsidiaries’ ability to pay dividends;
|
•
|
create liens on the Company’s assets or engage in sale/leaseback transactions; and
|
•
|
effect a consolidation or merger, or sell, transfer, or lease all or substantially all of the Company’s assets.
|
|
Asset Derivatives (Classified in Other Current Assets and Other Assets)
|
Liability Derivatives (Classified in Accrued Expenses and Other Liabilities)
|
|||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
||||||||
Contracts designated as cash flow hedges:
|
|
|
|
|
|
|
|
||||||||
Foreign currency forward exchange contracts (inventory purchases)
|
$
|
1,432
|
|
|
$
|
18,828
|
|
|
$
|
4,231
|
|
|
$
|
866
|
|
Interest rate contracts
|
4,110
|
|
|
45
|
|
|
8,097
|
|
|
6,729
|
|
||||
Total contracts designated as cash flow hedges
|
5,542
|
|
|
18,873
|
|
|
12,328
|
|
|
7,595
|
|
||||
Undesignated contracts:
|
|
|
|
|
|
|
|
||||||||
Foreign currency forward exchange contracts (inventory purchases)
|
282
|
|
|
—
|
|
|
109
|
|
|
538
|
|
||||
Foreign currency forward exchange contracts (intercompany loans)
|
396
|
|
|
—
|
|
|
767
|
|
|
111
|
|
||||
Total undesignated contracts
|
678
|
|
|
—
|
|
|
876
|
|
|
649
|
|
||||
Total
|
$
|
6,220
|
|
|
$
|
18,873
|
|
|
$
|
13,204
|
|
|
$
|
8,244
|
|
|
|
Gain (Loss) Recognized in Other Comprehensive (Loss) Income (Effective Portion)
|
|
(Loss) Gain Reclassified from AOCI into (Expense) Income (Effective Portion)
|
|||||||||||||
|
|
|
Location
|
Amount
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
Thirteen Weeks Ended
|
|
8/4/13
|
|
7/29/12
|
|
|
8/4/13
|
|
7/29/12
|
||||||||
Foreign currency forward exchange contracts (inventory purchases)
|
|
$
|
1,732
|
|
|
$
|
6,592
|
|
|
Cost of goods sold
|
$
|
(280
|
)
|
|
$
|
1,007
|
|
Interest rate contracts
|
|
(897
|
)
|
|
(962
|
)
|
|
Interest expense
|
(1,023
|
)
|
|
(1,098
|
)
|
||||
Total
|
|
$
|
835
|
|
|
$
|
5,630
|
|
|
|
$
|
(1,303
|
)
|
|
$
|
(91
|
)
|
|
|
|
|
|
|
|
|
|
|
||||||||
Twenty-Six Weeks Ended
|
|
8/4/13
|
|
7/29/12
|
|
|
8/4/13
|
|
7/29/12
|
||||||||
Foreign currency forward exchange contracts (inventory purchases)
|
|
$
|
10,590
|
|
|
$
|
4,916
|
|
|
Cost of goods sold
|
$
|
2,901
|
|
|
$
|
3,631
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
|
(1,106
|
)
|
|
(1,002
|
)
|
|
Interest expense
|
(2,177
|
)
|
|
(2,180
|
)
|
||||
Total
|
|
$
|
9,484
|
|
|
$
|
3,914
|
|
|
|
$
|
724
|
|
|
$
|
1,451
|
|
|
Gain (Loss) Recognized in Income
|
||||||||
Thirteen Weeks Ended
|
Location
|
|
8/4/13
|
|
7/29/12
|
||||
|
|
|
|
|
|
||||
Foreign currency forward exchange contracts (inventory purchases)
|
Selling, general and administrative expenses
|
|
$
|
661
|
|
|
$
|
(190
|
)
|
Foreign currency forward exchange contracts (intercompany loans)
|
Selling, general and administrative expenses
|
|
(285
|
)
|
|
(1,224
|
)
|
||
|
|
|
|
|
|
||||
Twenty-Six Weeks Ended
|
Location
|
|
8/4/13
|
|
7/29/12
|
||||
|
|
|
|
|
|
||||
Foreign currency forward exchange contracts (inventory purchases)
|
Selling, general and administrative expenses
|
|
$
|
349
|
|
|
$
|
679
|
|
Foreign currency forward exchange contracts (intercompany loans)
|
Selling, general and administrative expenses
|
|
(38
|
)
|
|
(1,224
|
)
|
|
8/4/13
|
|
2/3/13
|
|
7/29/12
|
||||||||||||||||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Foreign currency forward exchange contracts
|
N/A
|
|
$
|
2,110
|
|
|
N/A
|
|
$
|
2,110
|
|
|
N/A
|
|
$
|
4,693
|
|
|
N/A
|
|
$
|
4,693
|
|
|
N/A
|
|
$
|
18,828
|
|
|
N/A
|
|
$
|
18,828
|
|
||||||
Interest rate contracts
|
N/A
|
|
4,110
|
|
|
N/A
|
|
4,110
|
|
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
45
|
|
|
N/A
|
|
45
|
|
||||||||||||||
Total Assets
|
N/A
|
|
$
|
6,220
|
|
|
N/A
|
|
$
|
6,220
|
|
|
N/A
|
|
$
|
4,693
|
|
|
N/A
|
|
$
|
4,693
|
|
|
N/A
|
|
$
|
18,873
|
|
|
N/A
|
|
$
|
18,873
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Foreign currency forward exchange contracts
|
N/A
|
|
$
|
5,107
|
|
|
N/A
|
|
$
|
5,107
|
|
|
N/A
|
|
$
|
13,460
|
|
|
N/A
|
|
$
|
13,460
|
|
|
N/A
|
|
$
|
1,515
|
|
|
N/A
|
|
$
|
1,515
|
|
||||||
Interest rate contracts
|
N/A
|
|
8,097
|
|
|
N/A
|
|
8,097
|
|
|
N/A
|
|
5,058
|
|
|
N/A
|
|
5,058
|
|
|
N/A
|
|
6,729
|
|
|
N/A
|
|
6,729
|
|
||||||||||||
Contingent purchase price payments related to reacquisition of the perpetual rights to the
Tommy Hilfiger
trademarks in India
|
N/A
|
|
N/A
|
|
$
|
6,649
|
|
|
6,649
|
|
|
N/A
|
|
N/A
|
|
$
|
7,003
|
|
|
7,003
|
|
|
N/A
|
|
N/A
|
|
$
|
9,021
|
|
|
9,021
|
|
|||||||||
Total Liabilities
|
N/A
|
|
$
|
13,204
|
|
|
$
|
6,649
|
|
|
$
|
19,853
|
|
|
N/A
|
|
$
|
18,518
|
|
|
$
|
7,003
|
|
|
$
|
25,521
|
|
|
N/A
|
|
$
|
8,244
|
|
|
$
|
9,021
|
|
|
$
|
17,265
|
|
|
Twenty-Six Weeks Ended
|
||||||
|
8/4/13
|
|
7/29/12
|
||||
Beginning Balance
|
$
|
7,003
|
|
|
$
|
9,559
|
|
Payments
|
—
|
|
|
—
|
|
||
Adjustments included in earnings
|
(354
|
)
|
|
(538
|
)
|
||
Ending Balance
|
$
|
6,649
|
|
|
$
|
9,021
|
|
Unobservable Inputs
|
|
Amount
|
|
Approximate compounded annual net sales growth rate
|
|
45.0
|
%
|
Approximate
discount rate
|
|
20.0
|
%
|
|
8/4/13
|
|
2/3/13
|
|
7/29/12
|
||||||||||||||||||
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents
|
$
|
628,920
|
|
|
$
|
628,920
|
|
|
$
|
892,209
|
|
|
$
|
892,209
|
|
|
$
|
261,986
|
|
|
$
|
261,986
|
|
Short-term borrowings
|
3,447
|
|
|
3,447
|
|
|
10,847
|
|
|
10,847
|
|
|
52,791
|
|
|
52,791
|
|
||||||
Long-term debt (including portion classified as current)
|
4,280,151
|
|
|
4,358,547
|
|
|
2,299,642
|
|
|
2,398,200
|
|
|
1,803,485
|
|
|
1,886,289
|
|
|
Twenty-Six Weeks Ended
|
||||||
|
8/4/13
|
|
7/29/12
|
||||
Weighted average risk-free interest rate
|
1.05
|
%
|
|
1.20
|
%
|
||
Weighted average expected option term (in years)
|
6.22
|
|
|
6.25
|
|
||
Weighted average Company volatility
|
45.20
|
%
|
|
45.16
|
%
|
||
Expected annual dividends per share
|
$
|
0.15
|
|
|
$
|
0.15
|
|
Weighted average grant date fair value per option
|
$
|
51.51
|
|
|
$
|
40.59
|
|
|
Twenty-Six Weeks Ended
|
||
|
8/4/13
|
||
Weighted average risk-free interest rate
|
0.24
|
%
|
|
Weighted average expected option term (in years)
|
1.70
|
|
|
Weighted average Company volatility
|
29.40
|
%
|
|
Expected annual dividends per share
|
$
|
0.15
|
|
Weighted average grant date fair value per option
|
$
|
40.60
|
|
|
Options
|
|
Weighted Average Price Per Option
|
|||
Outstanding at February 3, 2013
|
1,958
|
|
|
$
|
44.17
|
|
Replacement of Warnaco awards
|
443
|
|
|
86.26
|
|
|
Granted
|
182
|
|
|
117.03
|
|
|
Exercised
|
381
|
|
|
64.43
|
|
|
Cancelled
|
12
|
|
|
93.60
|
|
|
Outstanding at August 4, 2013
|
2,190
|
|
|
$
|
54.95
|
|
Exercisable at August 4, 2013
|
1,511
|
|
|
$
|
42.83
|
|
|
RSUs
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested at February 3, 2013
|
660
|
|
|
$
|
62.24
|
|
Replacement of Warnaco awards
|
120
|
|
|
120.72
|
|
|
Granted
|
234
|
|
|
119.06
|
|
|
Vested
|
244
|
|
|
61.24
|
|
|
Cancelled
|
24
|
|
|
79.78
|
|
|
Non-vested at August 4, 2013
|
746
|
|
|
$
|
89.25
|
|
|
Restricted Stock
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested at February 3, 2013
|
—
|
|
|
$
|
—
|
|
Replacement of Warnaco awards
|
271
|
|
|
120.72
|
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
174
|
|
|
120.72
|
|
|
Cancelled
|
8
|
|
|
120.72
|
|
|
Non-vested at August 4, 2013
|
89
|
|
|
$
|
120.72
|
|
|
Twenty-Six Weeks Ended
|
||
|
8/4/13
|
||
Risk-free interest rate
|
0.34
|
%
|
|
Expected Company volatility
|
38.67
|
%
|
|
Expected annual dividends per share
|
$
|
0.15
|
|
Grant date fair value per performance share unit
|
$
|
123.27
|
|
|
Performance Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested at February 3, 2013
|
594
|
|
|
$
|
57.08
|
|
Granted
|
920
|
|
|
122.57
|
|
|
Vested
|
498
|
|
|
51.07
|
|
|
Cancelled
|
36
|
|
|
122.45
|
|
|
Non-vested at August 4, 2013
|
980
|
|
|
$
|
119.26
|
|
|
Foreign currency translation adjustments
|
|
Retirement liability adjustment
|
|
Net unrealized and realized (loss) gain on effective hedges
|
|
Total
|
||||||||
Balance at February 3, 2013
|
$
|
153,648
|
|
|
$
|
1,552
|
|
|
$
|
(15,318
|
)
|
|
$
|
139,882
|
|
Other comprehensive (loss) income before reclassifications
|
(149,019
|
)
|
|
—
|
|
|
9,503
|
|
|
(139,516
|
)
|
||||
Less: Amounts reclassified from AOCI
|
—
|
|
|
271
|
|
|
(11
|
)
|
|
260
|
|
||||
Other comprehensive (loss) income
|
(149,019
|
)
|
|
(271
|
)
|
|
9,514
|
|
|
(139,776
|
)
|
||||
Balance at August 4, 2013
|
$
|
4,629
|
|
|
$
|
1,281
|
|
|
$
|
(5,804
|
)
|
|
$
|
106
|
|
|
Amount Reclassified from AOCI
|
Affected Line Item in the Consolidated Income Statements
|
||||||
|
Thirteen Weeks Ended 8/4/13
|
|
Twenty-Six Weeks Ended 8/4/13
|
|
||||
Realized (loss) gain on effective hedges
|
|
|
|
|
||||
Foreign currency forward exchange contracts
|
$
|
(280
|
)
|
|
$
|
2,901
|
|
Cost of goods sold
|
Interest rate contracts
|
(1,023
|
)
|
|
(2,177
|
)
|
Interest expense
|
||
Less: Tax effect
|
(391
|
)
|
|
735
|
|
Income tax expense
|
||
Total, net of tax
|
$
|
(912
|
)
|
|
$
|
(11
|
)
|
|
|
|
|
|
|
||||
Amortization of retirement liability items
|
|
|
|
|
||||
Prior service credit
|
$
|
219
|
|
|
$
|
439
|
|
Selling, general and administrative expenses
|
Less: Tax effect
|
84
|
|
|
168
|
|
Income tax expense
|
||
Total, net of tax
|
$
|
135
|
|
|
$
|
271
|
|
|
|
Total Expected to be Incurred
|
|
Incurred During the Thirteen Weeks Ended 8/4/13
|
|
Incurred During the Twenty-Six Weeks Ended 8/4/13
|
|
Liability at 8/4/13
|
||||||||
Severance, termination benefits and other costs
|
$
|
175,000
|
|
|
$
|
40,839
|
|
|
$
|
97,952
|
|
|
$
|
44,130
|
|
Inventory liquidation costs
|
30,000
|
|
|
—
|
|
|
30,000
|
|
|
5,035
|
|
||||
Lease/contract termination and related costs
|
50,000
|
|
|
3,289
|
|
|
3,880
|
|
|
1,373
|
|
||||
Total
|
$
|
255,000
|
|
|
$
|
44,128
|
|
|
$
|
131,832
|
|
|
$
|
50,538
|
|
|
Liability at 2/3/13
|
|
Costs Incurred During the Twenty-Six Weeks Ended 8/4/13
|
|
Costs Paid During the Twenty-Six Weeks Ended 8/4/13
|
|
Liability at 8/4/13
|
||||||||
Severance, termination benefits and other costs
|
$
|
763
|
|
|
$
|
—
|
|
|
$
|
422
|
|
|
$
|
341
|
|
Lease/contract termination and related costs
|
2,013
|
|
|
—
|
|
|
847
|
|
|
1,166
|
|
||||
Total
|
$
|
2,776
|
|
|
$
|
—
|
|
|
$
|
1,269
|
|
|
$
|
1,507
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Net (loss) income attributable to PVH Corp.
|
$
|
(15,996
|
)
|
|
$
|
89,918
|
|
|
$
|
(36,048
|
)
|
|
$
|
185,394
|
|
Less:
|
|
|
|
|
|
|
|
||||||||
Common stock dividends paid to holders of Series A convertible preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
(209
|
)
|
||||
Allocation of income to Series A convertible preferred stock
|
—
|
|
|
(2,591
|
)
|
|
—
|
|
|
(6,936
|
)
|
||||
Net (loss) income available to common stockholders for basic net (loss) income per common share
|
(15,996
|
)
|
|
87,327
|
|
|
(36,048
|
)
|
|
178,249
|
|
||||
Add back:
|
|
|
|
|
|
|
|
||||||||
Common stock dividends paid to holders of Series A convertible preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
209
|
|
||||
Allocation of income to Series A convertible preferred stock
|
—
|
|
|
2,591
|
|
|
—
|
|
|
6,936
|
|
||||
Net (loss) income available to common stockholders for diluted net (loss) income per common share
|
$
|
(15,996
|
)
|
|
$
|
89,918
|
|
|
$
|
(36,048
|
)
|
|
$
|
185,394
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding for basic net (loss) income per common share
|
81,337
|
|
|
70,403
|
|
|
80,653
|
|
|
69,471
|
|
||||
Weighted average impact of dilutive securities
|
—
|
|
|
1,105
|
|
|
—
|
|
|
1,346
|
|
||||
Weighted average impact of assumed convertible preferred stock conversion
|
—
|
|
|
2,095
|
|
|
—
|
|
|
2,785
|
|
||||
Total shares for diluted net (loss) income per common share
|
81,337
|
|
|
73,603
|
|
|
80,653
|
|
|
73,602
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Basic net (loss) income per common share attributable to PVH Corp.
|
$
|
(0.20
|
)
|
|
$
|
1.24
|
|
|
$
|
(0.45
|
)
|
|
$
|
2.57
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted net (loss) income per common share attributable to PVH Corp.
|
$
|
(0.20
|
)
|
|
$
|
1.22
|
|
|
$
|
(0.45
|
)
|
|
$
|
2.52
|
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
|
|
|
|
|
|
|
|
Weighted average potentially dilutive securities
|
3,913
|
|
466
|
|
3,799
|
|
360
|
|
Thirteen Weeks Ended
|
|
Twenty-Six Weeks Ended
|
|||||||||||||
|
8/4/13
|
|
7/29/12
|
|
8/4/13
|
|
7/29/12
|
|||||||||
Revenue – Calvin Klein North America
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
$
|
332,119
|
|
|
$
|
150,546
|
|
|
$
|
625,459
|
|
|
$
|
312,520
|
|
|
Royalty revenue
|
22,610
|
|
|
28,891
|
|
|
48,026
|
|
|
60,199
|
|
|||||
Advertising and other revenue
|
8,024
|
|
|
14,201
|
|
|
16,719
|
|
|
26,075
|
|
|||||
Total
|
362,753
|
|
|
193,638
|
|
|
690,204
|
|
|
398,794
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Revenue – Calvin Klein International
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
286,152
|
|
|
12,124
|
|
|
541,340
|
|
(1
|
)
|
21,869
|
|
||||
Royalty revenue
|
15,796
|
|
|
30,355
|
|
|
34,149
|
|
|
64,520
|
|
|||||
Advertising and other revenue
|
5,884
|
|
|
15,114
|
|
|
12,750
|
|
|
28,167
|
|
|||||
Total
|
307,832
|
|
|
57,593
|
|
|
588,239
|
|
|
114,556
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Revenue – Tommy Hilfiger North America
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
357,081
|
|
|
324,482
|
|
|
694,757
|
|
|
623,462
|
|
|||||
Royalty revenue
|
6,034
|
|
|
5,101
|
|
|
12,524
|
|
|
9,625
|
|
|||||
Advertising and other revenue
|
1,748
|
|
|
2,285
|
|
|
4,206
|
|
|
3,972
|
|
|||||
Total
|
364,863
|
|
|
331,868
|
|
|
711,487
|
|
|
637,059
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Revenue – Tommy Hilfiger International
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
420,485
|
|
|
375,495
|
|
|
872,271
|
|
|
829,345
|
|
|||||
Royalty revenue
|
12,810
|
|
|
13,078
|
|
|
24,563
|
|
|
23,358
|
|
|||||
Advertising and other revenue
|
1,138
|
|
|
1,465
|
|
|
2,352
|
|
|
2,509
|
|
|||||
Total
|
434,433
|
|
|
390,038
|
|
|
899,186
|
|
|
855,212
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Revenue – Heritage Brands Wholesale
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
328,540
|
|
|
183,500
|
|
|
683,109
|
|
|
437,618
|
|
|||||
Royalty revenue
|
4,158
|
|
|
3,859
|
|
|
8,150
|
|
|
7,839
|
|
|||||
Advertising and other revenue
|
762
|
|
|
1,189
|
|
|
1,366
|
|
|
2,357
|
|
|||||
Total
|
333,460
|
|
|
188,548
|
|
|
692,625
|
|
|
447,814
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Revenue – Heritage Brands Retail
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
160,062
|
|
|
173,473
|
|
|
290,548
|
|
|
307,655
|
|
|||||
Royalty revenue
|
1,153
|
|
|
1,229
|
|
|
2,216
|
|
|
2,432
|
|
|||||
Advertising and other revenue
|
291
|
|
|
236
|
|
|
502
|
|
|
507
|
|
|||||
Total
|
161,506
|
|
|
174,938
|
|
|
293,266
|
|
|
310,594
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
Total Revenue
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
1,884,439
|
|
|
1,219,620
|
|
|
3,707,484
|
|
|
2,532,469
|
|
|||||
Royalty revenue
|
62,561
|
|
|
82,513
|
|
|
129,628
|
|
|
167,973
|
|
|||||
Advertising and other revenue
|
17,847
|
|
|
34,490
|
|
|
37,895
|
|
|
63,587
|
|
|||||
Total
|
$
|
1,964,847
|
|
|
$
|
1,336,623
|
|
|
$
|
3,875,007
|
|
|
$
|
2,764,029
|
|
(1)
|
Includes $
30,000
of sales returns for certain Warnaco wholesale customers in Asia in connection with the Company’s initiative to reduce excess inventory levels.
|
|
Thirteen Weeks Ended
|
|
|
Twenty-Six Weeks Ended
|
|
||||||||||||||
|
8/4/13
|
|
|
7/29/12
|
|
|
8/4/13
|
|
|
7/29/12
|
|
||||||||
Income before interest and taxes – Calvin Klein North America
|
$
|
39,496
|
|
(2)
|
|
$
|
36,412
|
|
|
|
$
|
51,934
|
|
(3)
|
|
$
|
72,490
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
(Loss) income before interest and taxes – Calvin Klein International
|
(56,878
|
)
|
(2)
|
|
23,777
|
|
|
|
(105,032
|
)
|
(3)
|
|
46,003
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income before interest and taxes – Tommy Hilfiger North America
|
61,960
|
|
|
|
52,636
|
|
|
|
107,970
|
|
|
|
81,513
|
|
(6)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income before interest and taxes – Tommy Hilfiger International
|
37,859
|
|
|
|
41,113
|
|
(5)
|
|
110,001
|
|
|
|
114,593
|
|
(6)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income before interest and taxes – Heritage Brands Wholesale
|
29,149
|
|
(2)
|
|
13,797
|
|
|
|
57,504
|
|
(3)
|
|
34,037
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income (loss) before interest and taxes – Heritage Brands Retail
|
4,013
|
|
|
|
9,306
|
|
|
|
(2,790
|
)
|
|
|
6,710
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Loss before interest and taxes – Corporate
(1)
|
(42,166
|
)
|
(2)
|
|
(23,787
|
)
|
(5)
|
|
(139,369
|
)
|
(3)(4)
|
|
(46,010
|
)
|
(6)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Income before interest and taxes
|
$
|
73,433
|
|
|
|
$
|
153,254
|
|
|
|
$
|
80,218
|
|
|
|
$
|
309,336
|
|
|
(1)
|
Includes corporate expenses not allocated to any reportable segments. Corporate expenses represent overhead operating expenses and include expenses for senior corporate management, corporate finance, information technology related to corporate infrastructure and actuarial gains and losses from the Company’s pension and other postretirement plans.
|
(2)
|
Income (loss) before interest and taxes for the
thirteen weeks ended
August 4, 2013
includes costs of
$139,886
associated with the Company’s acquisition and integration of Warnaco and the related restructuring. Such costs were included in the Company’s segments as follows: $
27,632
in Calvin Klein North America; $
85,008
in Calvin Klein International; $
11,247
in Heritage Brands Wholesale and $
15,999
in corporate expenses not allocated to any reportable segments.
|
(3)
|
Income (loss) before interest and taxes for the
twenty-six weeks ended
August 4, 2013
includes costs of
$333,993
associated with the Company’s acquisition and integration of Warnaco and the related restructuring. Such costs were included in the Company’s segments as follows:
$68,734
in Calvin Klein North America;
$185,468
in Calvin Klein International;
$28,770
in Heritage Brands Wholesale and
$51,021
in corporate expenses not allocated to any reportable segments.
|
(4)
|
Loss before interest and taxes for the
twenty-six weeks ended
August 4, 2013
includes costs of $
40,395
associated with the Company’s debt modification and extinguishment. Please refer to Note 8, “Debt,” for a further discussion.
|
(5)
|
Income (loss) before interest and taxes for the
thirteen weeks ended
July 29, 2012 includes costs of $
4,541
associated with the Company’s integration of Tommy Hilfiger and the related restructuring. Such costs were included in the Company’s segments as follows: $
3,497
in Tommy Hilfiger International and $
1,044
in corporate expenses not allocated to any reportable segments.
|
(6)
|
Income (loss) before interest and taxes for the
twenty-six weeks ended
July 29, 2012 includes costs of $
7,857
associated with the Company’s integration of Tommy Hilfiger and the related restructuring. Such costs were included in the Company’s segments as follows: $
379
in Tommy Hilfiger North America; $
3,497
in Tommy Hilfiger International and $
3,981
in corporate expenses not allocated to any reportable segments.
|
Identifiable Assets
|
|
8/4/13
|
|
2/3/13
|
|
7/29/12
|
||||||
Calvin Klein North America
|
|
$
|
1,907,589
|
|
|
$
|
752,029
|
|
|
$
|
719,391
|
|
Calvin Klein International
|
|
3,182,654
|
|
|
584,860
|
|
|
578,037
|
|
|||
Tommy Hilfiger North America
|
|
1,220,896
|
|
|
1,137,404
|
|
|
1,139,287
|
|
|||
Tommy Hilfiger International
|
|
3,209,996
|
|
|
3,278,813
|
|
|
2,981,087
|
|
|||
Heritage Brands Wholesale
|
|
1,370,895
|
|
|
555,544
|
|
|
568,847
|
|
|||
Heritage Brands Retail
|
|
206,313
|
|
|
175,717
|
|
|
185,756
|
|
|||
Corporate
(1)
|
|
416,403
|
|
|
1,297,182
|
|
|
559,083
|
|
|||
Total
|
|
$
|
11,514,746
|
|
|
$
|
7,781,549
|
|
|
$
|
6,731,488
|
|
References to the brand names
Calvin Klein
,
Tommy Hilfiger
,
Van Heusen
,
IZOD
,
ARROW
,
G.H. Bass & Co.
,
Warner’s
,
Olga
and
Speedo
and to other brand names are to registered trademarks owned by us or licensed to us by third parties and are identified by italicizing the brand name.
References to the acquisition of Warnaco refer to our February 13, 2013 acquisition of The Warnaco Group, Inc. and its subsidiaries, which we refer to collectively as “Warnaco.” References to the acquisition of Tommy Hilfiger refer to our May 6, 2010 acquisition of Tommy Hilfiger B.V. and certain affiliated companies, which we refer to collectively as “Tommy Hilfiger.” |
•
|
The aggregate addition of $456 million of net sales in our Calvin Klein North America and Calvin Klein International segments. The newly-acquired Calvin Klein businesses contributed $411 million of this increase. In addition, comparable store sales within our Calvin Klein North America retail business increased 6%, while our pre-acquisition Calvin Klein North America wholesale sportswear business experienced strong double-digit growth. Comparable store sales within the Calvin Klein International segment (which relate to newly acquired businesses) decreased 1%. The Calvin Klein businesses in China and Brazil continued to exhibit strong momentum, and the Korea business showed some improvement over first quarter trends. The Calvin Klein European business remained under pressure, as the jeans business is in transition and continues to be weak in Spain and Italy, where it is primarily concentrated. In addition, wholesale revenue in Europe decreased as we continued to rationalize our wholesale distribution to focus on accounts that we view as brand-enhancing and more creditworthy.
|
•
|
The aggregate addition of $78 million of net sales attributable to growth in our Tommy Hilfiger North America and Tommy Hilfiger International segments. Within the Tommy Hilfiger North America segment, net sales increased 10%, principally driven by retail comparable store sales growth of 7% and retail square footage expansion. Net sales in the
|
•
|
The aggregate addition of $132 million of net sales in our Heritage Brands Wholesale and Heritage Brands Retail segments, driven by the net impact of: (i) the addition of $131 million of net sales in our Heritage Brands Wholesale segment attributed to Warnaco’s Speedo swim product and Warner’s and Olga women’s intimate apparel businesses; (ii) strength in the wholesale dress furnishings and Van Heusen and Izod men’s wholesale sportswear businesses; (iii) a 10% decrease in retail comparable store sales due in large part to the continued soft performance of the Bass retail business; and (iv) a negative impact of $8 million resulting from the 2012 exit from the Izod women’s and Timberland wholesale sportswear businesses.
|
•
|
The aggregate addition of $832 million of net sales in our Calvin Klein North America and Calvin Klein International segments. The newly acquired Calvin Klein businesses contributed $807 million of this increase. In addition, our Calvin Klein North America retail business experienced a 5% increase in comparable store sales and our pre-acquisition Calvin Klein North America wholesale sportswear business had a double-digit increase in net sales. With respect to the Warnaco Calvin Klein jeans and underwear businesses, strength in China and Latin America was partially offset by continued weakness in Korea. The Calvin Klein European business remained under pressure, as the jeans business is in transition and continues to be weak in Spain and Italy, where it is primarily concentrated. Wholesale revenue in Europe decreased as we continued to rationalize our wholesale distribution to focus on accounts that we view as brand-enhancing and more creditworthy. In addition, net sales in the Calvin Klein International segment in the current year include a reduction of $30 million due to sales returns for certain Warnaco wholesale customers in Asia in connection with an initiative to reduce excess inventory levels.
|
•
|
The aggregate addition of $114 million of net sales attributable to growth in our Tommy Hilfiger North America and Tommy Hilfiger International segments. Within the Tommy Hilfiger North America segment, net sales increased 11%, principally driven by comparable store sales growth of 6% and retail square footage expansion, combined with strong first quarter performance in the North America wholesale business. Net sales in the Tommy Hilfiger International segment increased 5% as compared to the prior year’s first half, driven by European retail comparable store sales growth of 5% and retail square footage expansion, partially offset by a revenue decline in Japan, where our efforts to strategically reposition the brand are continuing.
|
•
|
The aggregate addition of $228 million of net sales in our Heritage Brands Wholesale and Heritage Brands Retail segments, driven by the net impact of: (i) the addition of $257 million of net sales in our Heritage Brands Wholesale
|
(in millions)
|
August 4, 2013
|
|
February 3, 2013
|
|
July 29, 2012
|
||||||
Short-term borrowings
|
$
|
3
|
|
|
$
|
11
|
|
|
$
|
53
|
|
Current portion of long-term debt
|
85
|
|
|
88
|
|
|
88
|
|
|||
Capital lease obligations
|
27
|
|
|
31
|
|
|
35
|
|
|||
Long-term debt
|
4,195
|
|
|
2,212
|
|
|
1,715
|
|
|||
Stockholders’ equity
|
4,048
|
|
|
3,253
|
|
|
2,781
|
|
•
|
incur or guarantee additional debt or extend credit;
|
•
|
make restricted payments, including paying dividends or making distributions on, or redeeming or repurchasing, our capital stock or certain debt;
|
•
|
make acquisitions and investments;
|
•
|
dispose of assets;
|
•
|
engage in transactions with affiliates;
|
•
|
enter into agreements restricting our subsidiaries’ ability to pay dividends;
|
•
|
create liens on our assets or engage in sale/leaseback transactions; and
|
•
|
effect a consolidation or merger, or sell, transfer, or lease all or substantially all of our assets.
|
Period
|
(a) Total Number of Shares (or Units) Purchased
(1)
|
|
(b) Average Price Paid per Share (or Unit)
(1)
|
|
(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
|
|
(d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
|
|||||
May 6, 2013
|
|
|
|
|
|
|
|
|||||
June 2, 2013
|
2,472
|
|
|
$
|
110.21
|
|
|
—
|
|
|
—
|
|
June 3, 2013
|
|
|
|
|
|
|
|
|||||
July 7, 2013
|
299,794
|
|
|
120.86
|
|
|
—
|
|
|
—
|
|
|
July 8, 2013
|
|
|
|
|
|
|
|
|||||
August 4, 2013
|
3,829
|
|
|
127.00
|
|
|
—
|
|
|
—
|
|
|
Total
|
306,095
|
|
|
$
|
120.85
|
|
|
—
|
|
|
—
|
|
The following exhibits are included herein:
|
|||
|
|
|
|
3.1
|
|
|
Certificate of Incorporation (incorporated by reference to Exhibit 5 to the Company’s Annual Report on Form 10-K for the fiscal year ended January 29, 1977); Amendment to Certificate of Incorporation, filed June 27, 1984 (incorporated by reference to Exhibit 3B to the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 1985); Amendment to Certificate of Incorporation, filed June 2, 1987 (incorporated by reference to Exhibit 3(c) to the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 1988); Amendment to Certificate of Incorporation, filed June 1, 1993 (incorporated by reference to Exhibit 3.5 to the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 1994); Amendment to Certificate of Incorporation, filed June 20, 1996 (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the period ended July 28, 1996); Certificate of Amendment of Certificate of Incorporation, filed June 29, 2006 (incorporated by reference to Exhibit 3.9 to the Company’s Quarterly Report on Form 10-Q for the period ended May 6, 2007); Certificate of Amendment of Certificate of Incorporation, filed June 23, 2011 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on June 29, 2011).
|
|
|
|
|
3.2
|
|
|
Certificate of Designation of Series A Cumulative Participating Preferred Stock, filed on June 10, 1986 (incorporated by reference to Exhibit A of the document filed as Exhibit 3 to the Company’s Quarterly Report on Form 10-Q for the period ended May 4, 1986).
|
|
|
|
|
3.3
|
|
|
Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock of Phillips-Van Heusen Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on February 26, 2003); Corrected Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock of Phillips-Van Heusen Corporation, dated as of April 17, 2003 (incorporated by reference to Exhibit 3.9 to the Company’s Annual Report on Form 10-K for the fiscal year ended February 2, 2003).
|
|
|
|
|
3.4
|
|
|
Certificate Eliminating Reference to Series B Convertible Preferred Stock From Certificate of Incorporation of Phillips-Van Heusen Corporation, filed on June 12, 2007 (incorporated by reference to Exhibit 3.10 to the Company’s Quarterly Report on Form 10-Q for the period ended May 6, 2007).
|
|
|
|
|
3.5
|
|
|
Certificate Eliminating Reference to Series A Cumulative Participating Preferred Stock From Certificate of Incorporation of Phillips-Van Heusen Corporation (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed on September 28, 2007).
|
|
|
|
|
3.6
|
|
|
Certificate of Designations of Series A Convertible Preferred Stock of Phillips-Van Heusen Corporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on May 12, 2010).
|
|
|
|
|
3.7
|
|
|
By-Laws of Phillips-Van Heusen Corporation, as amended through February 2, 2012 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on February 3, 2012).
|
|
|
|
|
3.8
|
|
|
Certificate Eliminating Reference to Series A Convertible Preferred Stock From Certificate of Incorporation of PVH Corp. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on May 3, 2013).
|
|
|
|
|
4.1
|
|
|
Specimen of Common Stock certificate (incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the period ended July 31, 2011).
|
|
|
|
4.2
|
|
|
Indenture, dated as of November 1, 1993, between Phillips-Van Heusen Corporation and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.01 to the Company’s Registration Statement on Form S-3 (Reg. No. 33-50751) filed on October 26, 1993); First Supplemental Indenture, dated as of October 17, 2002 to Indenture dated as of November 1, 1993 between Phillips-Van Heusen Corporation and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.15 to the Company’s Quarterly Report on Form 10-Q for the period ended November 3, 2002); Second Supplemental Indenture, dated as of February 12, 2002 to Indenture, dated as of November 1, 1993, between Phillips-Van Heusen Corporation and The Bank of New York, as Trustee (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed on February 26, 2003); Third Supplemental Indenture, dated as of May 6, 2010, between Phillips-Van Heusen Corporation and The Bank of New York Mellon (formerly known as The Bank of New York), as Trustee (incorporated by reference to Exhibit 4.16 to the Company’s Quarterly Report on Form 10-Q for the period ended August 1, 2010).
|
|
|
|
|
4.3
|
|
|
Securities Purchase Agreement, dated as of March 15, 2010, by and among Phillips-Van Heusen Corporation, LNK Partners, L.P. and LNK Partners (Parallel), L.P. (incorporated by reference to Exhibit 4.10 to the Company’s Quarterly Report on Form 10-Q for the period ended May 2, 2010).
|
|
|
|
|
4.4
|
|
|
Securities Purchase Agreement, dated as of March 15, 2010, by and between Phillips-Van Heusen Corporation and MSD Brand Investments, LLC (incorporated by reference to Exhibit 4.11 to the Company’s Quarterly Report on Form 10-Q for the period ended May 2, 2010).
|
|
|
|
|
4.5
|
|
|
Stockholders Agreement, dated as of May 6, 2010, by and among Phillips-Van Heusen Corporation, LNK Partners, L.P. and LNK Partners (Parallel), L.P. (incorporated by reference to Exhibit 4.13 to the Company’s Quarterly Report on Form 10-Q for the period ended August 1, 2010).
|
|
|
|
|
4.6
|
|
|
Stockholder Agreement, dated as of May 6, 2010, by and between Phillips-Van Heusen Corporation and MSD Brand Investments, LLC. (incorporated by reference to Exhibit 4.14 to the Company’s Quarterly Report on Form 10-Q for the period ended August 1, 2010).
|
|
|
|
|
4.7
|
|
|
Indenture, dated as of May 6, 2010, between Phillips-Van Heusen Corporation and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.15 to the Company’s Quarterly Report on Form 10-Q for the period ended August 1, 2010).
|
|
|
|
|
4.8
|
|
|
First Supplemental Indenture, dated as of November 8, 2012, to Indenture dated as of May 6, 2010, between PVH Corp. (formerly known as “Phillips-Van Heusen Corporation”) and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.9 to the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2013).
|
|
|
|
|
4.9
|
|
|
Indenture, dated as of December 20, 2012, between PVH Corp. and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K, filed on December 20, 2012).
|
|
|
|
|
4.10
|
|
|
Fourth Supplemental Indenture, dated as of February 13, 2013 to Indenture, dated as of November 1, 1993, between PVH Corp. and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.11 to the Company’s Quarterly Report on Form 10-Q for the period ended May 5, 2013).
|
|
|
|
|
10.1
|
|
|
PVH Corp. Performance Incentive Bonus Plan, as amended and restated effective May 2, 2013 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed June 26, 2013).
|
|
|
|
|
10.2
|
|
|
PVH Corp. Long-Term Incentive Plan, as amended and restated effective May 2, 2013 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed June 26, 2013).
|
|
|
|
|
+10.3
|
|
|
Third Amended and Restated Employment Agreement, dated as of July 1, 2013, between Calvin Klein, Inc. and Paul Thomas Murry.
|
|
|
|
|
+10.4
|
|
|
Amended and Restated Employment Agreement, dated as of July 23, 2013, between PVH B.V. and Fred Gehring.
|
|
|
|
|
+31.1
|
|
|
Certification of Emanuel Chirico, Chairman and Chief Executive Officer, pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
|
|
|
|
|
+31.2
|
|
|
Certification of Michael Shaffer, Executive Vice President and Chief Operating & Financial Officer, pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
|
|
|
|
|
*,+32.1
|
|
|
Certification of Emanuel Chirico, Chairman and Chief Executive Officer, pursuant to Section 906 of the Sarbanes – Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
|
|
*,+32.2
|
|
|
Certification of Michael Shaffer, Executive Vice President and Chief Operating & Financial Officer, pursuant to Section 906 of the Sarbanes – Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
|
|
+101.INS
|
|
|
XBRL Instance Document
|
|
|
|
|
+101.SCH
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
+101.CAL
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
+101.DEF
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
+101.LAB
|
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
+101.PRE
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
+Filed or furnished herewith.
|
|
PVH CORP.
|
|
Registrant
|
Dated:
|
September 12, 2013
|
/s/
Bruce Goldstein
|
|
|
Bruce Goldstein
|
|
|
Senior Vice President and Controller (Chief Accounting Officer)
|
|
|
10.3
|
Third Amended and Restated Employment Agreement, dated as of July 1, 2013, between Calvin Klein, Inc. and Paul Thomas Murry.
|
|
|
10.4
|
Amended and Restated Employment Agreement, dated as of July 23, 2013, between PVH B.V. and Fred Gehring.
|
|
|
31.1
|
Certification of Emanuel Chirico, Chairman and Chief Executive Officer, pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
|
|
|
31.2
|
Certification of Michael Shaffer, Executive Vice President and Chief Operating & Financial Officer, pursuant to Section 302 of the Sarbanes – Oxley Act of 2002.
|
|
|
32.1
|
Certification of Emanuel Chirico, Chairman and Chief Executive Officer, pursuant to Section 906 of the Sarbanes – Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
32.2
|
Certification of Michael Shaffer, Executive Vice President and Chief Operating & Financial Officer, pursuant to Section 906 of the Sarbanes – Oxley Act of 2002, 18 U.S.C. Section 1350.
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Richelle P. Parham has served as a director of the Company since February 2016 and Chair of the Compensation and Human Capital Committee since June 2023. Ms. Parham currently serves as the President of Global E-Commerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. Prior to Universal Music Group, Ms. Parham served as a Managing Director of WestRiver Group, which is a collaboration of leading investment firms that provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy, and experiential sectors from October 2019 to May 2021. She is also currently a Strategic Advisor at Camden Partners, a private equity firm, where she previously served as a General Partner from October 2016 to October 2019. Prior to Camden Partners, Ms. Parham served as Vice President, Chief Marketing Officer of eBay from November 2010 to March 2015. Ms. Parham was responsible, globally, for eBay brand strategy and brand marketing, to reach over 108+ million active eBay users, Internet marketing and for customer relationship management. Prior to joining eBay, Ms. Parham served as head of Global Marketing Innovation and Initiatives and head of Global Marketing Services at Visa, Inc. from 2008 to 2010. Ms. Parham founded and serves as Executive Chairman of the Board of Directors for Shyn, an oral care product company since January 2018. Her experience also includes 13 years at Digitas, Inc., a leading marketing agency, where she held a variety of senior leadership roles, including senior vice president and general manager of the agency’s Chicago office. Ms. Parham holds Bachelor of Science degrees in Business Administration and Design Arts from Drexel University. | |||
Peter M. Neupert has served as a director of the Company since January 2013. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. In addition, Mr. Neupert was a member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2007 to 2012, a workshop dedicated to transforming the way evidence on clinical effectiveness is generated and used to improve health and healthcare. Mr. Neupert also served on the U.S. President’s Information Technology Advisory Committee, co-chairing the Health Information Technology Subcommittee and helping to drive the “Revolutionizing Health Care Through Information Technology” report, published in June 2004. Mr. Neupert served as the founding President and Chief Executive Officer of drugstore.com from 1998 to 2001 and as Chairman of the board of directors through September 2004. Mr. Neupert holds a Master of Business Administration from the Tuck School of Business at Dartmouth College and a Bachelor of Arts in Philosophy from Colorado College. | |||
Paul B. Rothman has served as a director of the Company and member of the Quality and Compliance Committee since June 2023. He has served as the Chair of the Quality and Compliance Committee since June 2024. Dr. Rothman, a rheumatologist and molecular immunologist, was previously the Dean of the Medical Faculty for Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, during which time he oversaw both the Johns Hopkins Health System and the School of Medicine. Prior to serving at Johns Hopkins, Dr. Rothman held various leadership positions at Columbia University and the University of Iowa. Dr. Rothman holds a Bachelor of Science in Biology from the Massachusetts Institute of Technology and a Doctor of Medicine from Yale University. | |||
Professional Highlights Richelle P. Parham has served as a director of the Company since February 2016 and Chair of the Compensation and Human Capital Committee since June 2023. Ms. Parham currently serves as the President of Global E-Commerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. Prior to Universal Music Group, Ms. Parham served as a Managing Director of WestRiver Group, which is a collaboration of leading investment firms that provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy, and experiential sectors from October 2019 to May 2021. She is also currently a Strategic Advisor at Camden Partners, a private equity firm, where she previously served as a General Partner from October 2016 to October 2019. Prior to Camden Partners, Ms. Parham served as Vice President, Chief Marketing Officer of eBay from November 2010 to March 2015. Ms. Parham was responsible, globally, for eBay brand strategy and brand marketing, to reach over 108+ million active eBay users, Internet marketing and for customer relationship management. Prior to joining eBay, Ms. Parham served as head of Global Marketing Innovation and Initiatives and head of Global Marketing Services at Visa, Inc. from 2008 to 2010. Ms. Parham founded and serves as Executive Chairman of the Board of Directors for Shyn, an oral care product company since January 2018. Her experience also includes 13 years at Digitas, Inc., a leading marketing agency, where she held a variety of senior leadership roles, including senior vice president and general manager of the agency’s Chicago office. Ms. Parham holds Bachelor of Science degrees in Business Administration and Design Arts from Drexel University. Skills and Qualifications • Extensive senior-level executive experience, including in corporate finance, and mergers and acquisitions • More than 20 years of global strategy and marketing experience, as well as expertise in understanding consumers and the consumer decision journey Committees: • Compensation and Human Capital Committee (Chair) • Nominating and Corporate Governance Committee Current Public Company Board Experience: • Best Buy Co., Inc. Previous Public Company Board Experience: • Scripps Network Interactive Inc. • e.l.f. Beauty, Inc. Other Current Relevant Experience: • Drexel University, Board of Trustees | |||
Kirsten M. Kliphouse has served as a director of the Company since October 2022. Ms. Kliphouse previously served as the President of Google Cloud Americas, a position she held from March 2022 to July 2023, where she was responsible for leading and growing the sales, go-to-market, customer engagement, channel, and services organizations. At Google Cloud, she also served as the Global Chair of the Aspiring Leadership Academy and Women@Google Cloud. Prior to her position as President, Ms. Kliphouse served as President of the North American division of Google Cloud from June 2019 to March 2022. Prior to Google Cloud, Ms. Kliphouse was Senior Vice President at Red Hat, Inc., a subsidiary of International Business Machines Corporation, Chief Executive Officer of Yardarm Technologies, a hardware and software solutions company, and founder and Chief Executive Officer of Scaling Ventures, a technology investment and advisory firm. Prior to her position at Yardarm, Ms. Kliphouse spent more than 25 years at Microsoft, Inc., where she was part of the executive leadership team and held numerous executive positions in Enterprise Sales, Original Equipment Manufacturers (OEM), Partner and Channels, and as Corporate Vice President of Customer Support, Success and Professional Services, during which she led more than 10,000-employees globally. Ms. Kliphouse is a recipient of the Founders Award for her superior leadership and contributions to the business. Ms. Kliphouse holds a Bachelor of Science in Computer Information Sciences and Business from Muhlenberg College. | |||
Kerrii B. Anderson has served as a director of the Company since May 2006. Ms. Anderson was Chief Executive Officer of Wendy’s International, Inc., a restaurant operating and franchising company, from April 2006 until September 2008, when the company merged with Triarc. Ms. Anderson served as Executive Vice President and Chief Financial Officer of Wendy’s International from 2000 to 2006. Prior to this position, she was Chief Financial Officer, Senior Vice President of M/I Schottenstein Homes, Inc. from 1987 to 2000. Ms. Anderson holds a Bachelor of Arts in Business Administration from Elon University and a Master of Business Administration from the Fuqua School of Business at Duke University and is a Certified Public Accountant. | |||
Kathryn E. Wengel has served as a director of the Company since March 2021. Ms. Wengel currently serves as Executive Vice President, Chief Technical Operations and Risk Officer, and a member of the Executive Committee of Johnson & Johnson. Since joining Johnson & Johnson in 1988, Ms. Wengel has served in various positions of increasing responsibility across the enterprise, both in the United States and various locations globally, including Executive Vice President and Chief Global Supply Chain Officer from 2018 to January 2023, Worldwide Vice President, Chief Global Supply Chain Officer from March 2014 to July 2018, and Chief Quality Officer from April 2010 to March 2014. Ms. Wengel holds a Bachelor of Science in Civil Engineering and operations research from Princeton University. | |||
Jeffrey A. Davis has served as a director of the Company since December 2019 and Chairman of the Audit Committee since June 2023. Mr. Davis previously served as the Chief Financial Officer of Dollar Tree, Inc., a leading operator of discount variety stores, from October 2022 to March 2025. Prior to his time at Dollar Tree, Inc., Mr. Davis served as Chief Financial Officer of Qurate Retail Group, a leading retailer and media conglomerate comprised of eight retail brands including QVC, HSN, and Zulily from October 2018 through August 2022. Prior to Qurate Retail Group, Mr. Davis served as Chief Financial Officer of J. C. Penney Company Inc., a retail company, from July 2017 until September 2018. Prior to joining J. C. Penney, Mr. Davis served as Chief Financial Officer of Darden Restaurants, Inc., a restaurant operator, from July 2015 until March 2016 and Chief Financial Officer of the Walmart U.S. segment of Walmart Inc. from January 2014 to May 2015, and in various other positions of increasing responsibility at Walmart U.S. from 2006 to 2013. Mr. Davis’ experience also includes nine years in senior executive roles at Lakeland Tours LLC and McKesson Corporation. Mr. Davis is a certified public accountant and holds a Bachelor of Science in Accounting from the Pennsylvania State University and a Master of Business Administration from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh. | |||
D. Gary Gilliland has served as a director of the Company since April 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Center, a research organization, since January 2020. From January 2015 to January 2020, Dr. Gilliland previously served as President and Director of the Fred Hutchinson Cancer Center. Prior to that, he was the inaugural Vice Dean and Vice President for Precision Medicine at the University of Pennsylvania Perelman School of Medicine from October 2013 to January 2015, where he was responsible for synthesizing research and clinical-care initiatives across all medical disciplines including cancer, heart and vascular medicine, neurosciences, genetics, and pathology, to create a national model for the delivery of precise, personalized medicine. From 2009 until he joined Penn Medicine in 2013, Dr. Gilliland was Senior Vice President of Merck Research Laboratories and Oncology Franchise Head. At Merck, Dr. Gilliland oversaw first-in-human studies, proof-of-concept trials, and Phase II/III registration trials that included the development of pembrolizumab (anti-PD1) for treatment of cancer, and managed all preclinical and clinical oncology-licensing activities. Prior to joining Merck, Dr. Gilliland was a member of the faculty at Harvard Medical School for nearly 20 years, where he served as Professor of Medicine and a Professor of Stem Cell and Regenerative Biology. He was also an Investigator of the Howard Hughes Medical Institute from 1996 to 2009, Director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center from 2002 to 2009, and Director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute from 2004 to 2009. Dr. Gilliland has a Doctor of Philosophy in Microbiology from UCLA and a Doctor of Medicine from UCSF. | |||
Adam H. Schechter has served as a director of the Company since April 2013, President and Chief Executive Officer of the Company since November 2019, and Chairman of the Board since May 2020. Prior to that, Mr. Schechter was President of Global Human Health and an Executive Vice President of Merck & Co., Inc., a pharmaceutical company, from 2010 to 2018, where he was a member of Merck’s executive committee. He served as special advisor to the CEO of Merck from January 2019 to July 2019. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter holds a bachelor’s degree in biology from La Salle University and was awarded an honorary Doctor of Humane Letters degree from La Salle University in 2021. |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Non-Qualified Stock Options ($) |
Stock Awards ($) |
Non-Equity Incentive Plan Compensation ($) |
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||||||||||||||||||||||||||
ADAM H. SCHECHTER President and Chief Executive Officer |
2024 | $ | 1,416,077 | $ | - | $ | 3,015,965 | $ | 12,162,271 | $ | 2,113,816 | $ | - | $ | 619,225 | $ | 19,327,354 | ||||||||||||||||||||||||||||
2023 | $ | 1,373,692 | $ | - | $ | 2,250,072 | $ | 9,071,320 | $ | 2,346,018 | $ | - | $ | 938,253 | $ | 15,979,355 | |||||||||||||||||||||||||||||
2022 | $ | 1,317,500 | $ | - | $ | 2,142,125 | $ | 9,063,244 | $ | 1,675,221 | $ | - | $ | 729,207 | $ | 14,927,297 | |||||||||||||||||||||||||||||
JULIA A. WANG Executive Vice President and Chief Financial Officer |
2024 | $ | 55,769 | $ | - | $ | 638,067 | $ | 2,668,417 | $ | - | $ | - | $ | 133 | $ | 3,362,386 | ||||||||||||||||||||||||||||
BRIAN J. CAVENEY Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer |
2024 | $ | 660,769 | $ | - | $ | 451,666 | $ | 1,825,122 | $ | 604,039 | $ | - | $ | 26,161 | $ | 3,567,757 | ||||||||||||||||||||||||||||
2023 | $ | 617,635 | $ | - | $ | 432,955 | $ | 1,745,352 | $ | 609,719 | $ | - | $ | 70,782 | $ | 3,476,443 | |||||||||||||||||||||||||||||
2022 | $ | 538,000 | $ | - | $ | 343,045 | $ | 1,440,880 | $ | 641,792 | $ | - | $ | 44,750 | $ | 3,008,467 | |||||||||||||||||||||||||||||
ANITA Z. GRAHAM Executive Vice President and Chief Human Resources Officer |
2024 | $ | 569,154 | $ | 500,000 | $ | 218,548 | $ | 890,976 | $ | 481,437 | $ | - | $ | 25,432 | $ | 2,685,547 | ||||||||||||||||||||||||||||
2023 | $ | 420,000 | $ | 500,000 | $ | 196,708 | $ | 1,012,330 | $ | 405,331 | $ | - | $ | 21,622 | $ | 2,555,991 | |||||||||||||||||||||||||||||
MARK S. SCHROEDER Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer |
2024 | $ | 660,769 | $ | - | $ | 502,661 | $ | 2,027,426 | $ | 678,718 | $ | 280 | $ | 116,453 | $ | 3,986,307 | ||||||||||||||||||||||||||||
2023 | $ | 617,635 | $ | - | $ | 461,625 | $ | 1,892,720 | $ | 718,807 | $ | 13,815 | $ | 90,506 | $ | 3,795,108 | |||||||||||||||||||||||||||||
2022 | $ | 538,000 | $ | - | $ | 343,045 | $ | 1,440,880 | $ | 456,051 | $ | - | $ | 65,079 | $ | 2,843,055 | |||||||||||||||||||||||||||||
GLENN A. EISENBERG Executive Vice President and Former Chief Financial Officer |
2024 | $ | 830,462 | $ | - | $ | 655,645 | $ | 2,634,274 | $ | 826,440 | $ | - | $ | 55,087 | $ | 5,001,908 | ||||||||||||||||||||||||||||
2023 | $ | 805,462 | $ | - | $ | 615,878 | $ | 2,473,816 | $ | 917,054 | $ | - | $ | 144,567 | $ | 4,956,777 | |||||||||||||||||||||||||||||
2022 | $ | 780,500 | $ | - | $ | 586,988 | $ | 6,551,496 | $ | 661,630 | $ | - | $ | 101,879 | $ | 8,682,493 |
No Customers Found
Suppliers
Supplier name | Ticker |
---|---|
Dow Inc. | DOW |
DuPont de Nemours, Inc. | DD |
Eastman Chemical Company | EMN |
RPM International Inc. | RPM |
Westlake Chemical Corporation | WLK |
H.B. Fuller Company | FUL |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Schechter Adam H | - | 98,962 | 0 |
EISENBERG GLENN A | - | 31,289 | 0 |
BERBERIAN LANCE | - | 19,697 | 0 |
BERBERIAN LANCE | - | 15,921 | 0 |
ANDERSON KERRII B | - | 13,166 | 144 |
Kirchgraber Paul R | - | 12,946 | 0 |
Gilliland Dwight Gary | - | 8,656 | 0 |
van der Vaart Sandra D | - | 7,605 | 0 |
Schroeder Mark S | - | 6,687 | 0 |
Schroeder Mark S | - | 4,960 | 0 |
Summy Amy B. | - | 4,544 | 0 |
Oyegunwa Akinbolade | - | 3,464 | 0 |
Bailey Megan D. | - | 3,403 | 0 |
DiVincenzo Jonathan P. | - | 3,401 | 0 |
DiVincenzo Jonathan P. | - | 3,355 | 0 |
van der Vaart Sandra D | - | 2,171 | 0 |
Wilkinson Peter J | - | 2,087 | 0 |
Wilkinson Peter J | - | 2,054 | 0 |
Summy Amy B. | - | 1,669 | 0 |
Rothman Paul | - | 717 | 0 |
Kliphouse Kirsten Marie | - | 372 | 0 |